NASDAQ:FDMT

4D Molecular Therapeutics, Inc Earning Date

USA |NASDAQ |USD

FDMT Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
- Sep 30, 2021 - $-0.28 -
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
- Sep 30, 2021 - $14.58M $7.42M

FDMT Earnings Date & History Chart

FDMT Earnings & Revenue Forecast

FDMT Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-0.95 $-1.03 $-0.88
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $-2.57 $-2.62 $-2.52
Dec 2022 3 $-3.68 $-4.32 $-2.88

FDMT Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.95 $-0.95 $-0.84
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-2.62 $-2.62 $-2.84
Dec 2022 0 / 0 $-3.60 $-3.60 $-2.98

FDMT Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 2 $170.00K $0.00 $350.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 2 $16.93M $16.58M $17.28M
Dec 2022 2 $1.55M $0.00 $3.10M

FDMT Earnings Date & Revenue History

FDMT Earnings History

|
Show More
Show More

FDMT Revenue History

|
Show More
Show More

4d Molecular Therapeutics, Inc Next Earnings Date & Report

FDMT Aug 2021 (FQ) Earnings Date & Report Preview

4d Molecular Therapeutics, Inc Previous Earnings Dates & Reports

FDMT Previous Earnings Date & Report Recap: Jun 2021 (FQ)

4d Molecular Therapeutics, Inc's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.

FDMT's earnings per share (EPS) was $-0.28, beating the consensus analysts forecast of $-0.68 by 58.82%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -54.10%.

Revenues were $14.58M, better than the forecast of $14.58M by 0.00%, up by 629.00% from the previous quarter , and up by 301.32% from the same period last year.

The company reported a net income of $-7.59M.

Free cash flow for the quarter was $-16.94M , compared to $-16.01M last quarter and $-6.29M a year before.

FDMT Previous Earnings Date & Report Recap: Dec 2020 (FY)

4d Molecular Therapeutics, Inc's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

FDMT's earnings per share (EPS) was $-9.82.

Revenues were $13.61M, better than the forecast of $13.61M by 0.00%, and up by 94.85% from previous year's revenue.

The company reported a net income of $-56.69M.

4d Molecular Therapeutics, Inc reported a free cash flow of $-51.91M for its fiscal year, compared to $-39.91M a year ago.